πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 68 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10385319

Modified foot-and-mouth disease virus 3C proteases, compositions and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10183080

Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of

The Government of the United States of America, as represented by the Secretary of the Navy Β· Granted Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9687542

Rift valley fever virus replicon particles and use thereof

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9453239

Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag a

The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9079936

Derivatives of APF and methods of use

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8926987

Replication-competent adenoviral vectors

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673292

Pure populations of astrocyte restricted precursor cells and methods for isolation and use

THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8288359

Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8043623

Immunogenic peptides for the treatment of prostate and breast cancer

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7691386

Chimeric papillomavirus-like particles

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7402659

Thymic stromal lymphopoietin receptor molecules and uses thereof

THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7311916

Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7303751

Anti-plasmodium compositions and methods of use

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7303754

MVA expressing modified HIV envelope, gag, and pol genes

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7235232

Interferon alpha hybrids

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7235365

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Jun 26 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7045132

Streptococcus pneumoniae 37-kDa surface adhesin a protein

The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services, c/o Centers for Disease Control and Prevention Β· Granted Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7041498

Method for modulating processes mediated by farnesoid activated receptors

THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6955895

Thymic stromal lymphopoietin receptor molecules and uses thereof

THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Tue Oct 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6416957

Method for modulating process mediated by farnesoid activated receptors

THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired